Form 4: Centene Director Burdick Acquires Shares
Insider Transaction Report
Centene Director Kenneth A. Burdick reported the acquisition of 852 common shares and updated his beneficial ownership, including restricted stock units and options.
Summary
- Kenneth A. Burdick, a Director of Centene Corp (CNC), reported an acquisition of 852 shares of common stock on September 30, 2025.
- The acquisition price for these shares was $0, indicating a grant or award.
- Following this transaction, Mr. Burdick directly beneficially owns 338,371.924 shares of common stock, which includes 3,579 restricted stock units subject to vesting.
- He also indirectly beneficially owns 86,498 shares through the Burdick Family LLC, disclaiming beneficial ownership except for his pecuniary interest.
- Additionally, Mr. Burdick holds 10,000 direct common stock options with an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive due to a director's acquisition of shares, which can be interpreted as a sign of confidence, even if it's a grant. However, it's a routine filing with no major financial or strategic news.
Positives
- Director Kenneth A. Burdick acquired 852 shares of common stock, potentially signaling confidence in the company's future.
- The acquisition price of $0 suggests these shares were likely granted as part of compensation, aligning management's interests with shareholders.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a routine insider transaction report and does not provide information for broader industry trend analysis or competitive positioning.
Related Party Transactions
- Indirect beneficial ownership of 86,498 shares of common stock through the Burdick Family LLC, of which Mr. Burdick is a chief manager. Mr. Burdick disclaims beneficial ownership except to the extent of his pecuniary interest.
Stakeholder Impact
- Shareholders may view the director's acquisition of shares, particularly at a $0 price (likely a grant), as a positive signal of management's alignment with shareholder interests and confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date Common Stock Options become exercisable. |
| 09/30/2025 | Date of the reported transaction (acquisition of common stock). |
| 10/01/2025 | Date the Form 4 was signed by attorney-in-fact. |
| 02/07/2032 | Expiration date of Common Stock Options. |
Keywords
Centene, CNC, Form 4, Insider Transaction, Stock Acquisition, Director, Beneficial Ownership, Restricted Stock Units, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.